All Cosmos Bio-Tech Holding Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
For the six months, sales was TWD 1,577.61 million compared to TWD 975.37 million a year ago. Revenue was TWD 1,577.61 million compared to TWD 975.37 million a year ago. Net income was TWD 162.84 million compared to TWD 69.28 million a year ago. Basic earnings per share from continuing operations was TWD 2.54 compared to TWD 1.08 a year ago. Diluted earnings per share from continuing operations was TWD 2.54 compared to TWD 1.08 a year ago.